The Central Drugs Standard Control Organization (CDSCO) has moved to curb a widespread but problematic practice in India's pharmaceutical market: using the same brand name across multiple, unrelated drug products…
When you are sourcing generic medicines from India — whether for a hospital formulary, a government tender, or personal use — the WHO-GMP (World Health Organization Good Manufacturing Practice) certification…
The Central Drugs Standard Control Organization (CDSCO) has directed all pharmaceutical companies operating in India to establish and maintain robust adverse event (AE) reporting systems and pharmacovigilance (PV) programs for…
In June 2026, India's Central Drugs Standard Control Organisation (CDSCO) issued a directive requiring all pharmaceutical manufacturers in India to maintain a robust pharmacovigilance system for reporting adverse events (AEs)…